Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis-Reference-Cited by-同舟云学术

Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis

Published:2015-12 Issue:7 Volume:163 Page:1585-1595
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Wang Zeneng,Roberts Adam B.,Buffa Jennifer A.,Levison Bruce S.,Zhu Weifei,Org Elin,Gu Xiaodong,Huang Ying,Zamanian-Daryoush Maryam,Culley Miranda K.,DiDonato Anthony J.,Fu Xiaoming,Hazen Jennie E.,Krajcik Daniel,DiDonato Joseph A.,Lusis Aldons J.,Hazen Stanley L.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference36 articles.

1. Quantitative assay for mouse atherosclerosis in the aortic root;Baglione;Methods Mol. Med.,2006

2. Trimethylamine: metabolic, pharmacokinetic and safety aspects;Bain;Curr. Drug Metab.,2005

3. The effects of inhibiting choline dehydrogenase on choline metabolism in mice;Barlow;Biochem. Pharmacol.,1985

4. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation;Bennett;Cell Metab.,2013

5. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases;Brown;Annu. Rev. Med.,2015

Cited by 1015 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension;Microbiological Research;2024-10

2. The metabolic and endocrine impact of diet-derived gut microbiota metabolites on ageing and longevity;Ageing Research Reviews;2024-09

3. Metabolomic Applications in Gut Microbiota-Host Interactions in Human Diseases;Gastroenterology Clinics of North America;2024-09

4. Anthocyanins as natural bioactives with anti-hypertensive and atherosclerotic potential: Health benefits and recent advances;Phytomedicine;2024-09

5. The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis;Obesity Medicine;2024-09